BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1713845)

  • 21. Haematological toxicity compromises MOPP/ABVD chemotherapy in Hodgkin's disease.
    Goodrick MJ; Daniel F; Prentice AG; Copplestone JA; Tyrrell CJ
    Clin Oncol (R Coll Radiol); 1991 May; 3(3):151-4. PubMed ID: 1712627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal BG; Marcus R; Brecher M; Ternberg J; Behm FG; Cantor A; Wharam M; Chauvenet A
    J Clin Oncol; 1991 Sep; 9(9):1591-8. PubMed ID: 1714950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
    Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Najbar A; Radwańska U; Kaczmarek M; Ochocka M; Stańczak E; Sońta-Jakimczyk D
    Acta Paediatr Jpn; 1991 Dec; 33(6):703-8. PubMed ID: 1724869
    [No Abstract]   [Full Text] [Related]  

  • 24. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
    Oncology (Williston Park); 1996 Apr; 10(4):593-4. PubMed ID: 8723294
    [No Abstract]   [Full Text] [Related]  

  • 25. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 27. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
    Viviani S; Bonadonna G; Santoro A; Bonfante V; Zanini M; Devizzi L; Soncini F; Valagussa P
    J Clin Oncol; 1996 May; 14(5):1421-30. PubMed ID: 8622055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
    Longo DL
    J Natl Cancer Inst; 2003 Jul; 95(13):928-9. PubMed ID: 12837820
    [No Abstract]   [Full Text] [Related]  

  • 29. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Lira P; Grebe G
    Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597
    [No Abstract]   [Full Text] [Related]  

  • 31. Hodgkin's disease in children: adaptation of treatment to risk factors.
    Lemerle J; Oberlin O; Schaison G; Leverger G; Olive D; Bonnet M; Dufillot D; de Lumley L
    Recent Results Cancer Res; 1989; 117():214-21. PubMed ID: 2481330
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 33. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H; Stuve W; Behrendt H
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
    Glick JH; Tsiatis A
    Ann Intern Med; 1986 Jun; 104(6):876-8. PubMed ID: 2422998
    [No Abstract]   [Full Text] [Related]  

  • 36. Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
    Tombolini V; Capua A; Pompili E
    Acta Oncol; 1992; 31(1):64-5. PubMed ID: 1375043
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy for advanced Hodgkin's disease.
    Choudhry VP
    Indian J Pediatr; 1982; 49(401):823-5. PubMed ID: 6189783
    [No Abstract]   [Full Text] [Related]  

  • 38. [Our experiences in treating patients with Hodgkin disease in the last decade].
    Simon Z; Keresztes K; Miltényi Z; Ress Z; Váróczy L; Vadász G; Gergely L; Illés A
    Orv Hetil; 2007 Apr; 148(15):675-82. PubMed ID: 17416575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
    Hunger SP; Link MP; Donaldson SS
    J Clin Oncol; 1994 Oct; 12(10):2160-6. PubMed ID: 7523608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.